The Targeted Protein Degradation (TPD) approach has enabled a switch to event-driven pharmacology, providing a revolutionary new strategy to target proteins previously considered undruggable. Since 2016, WuXi AppTec has been diligently building an integrated research platform encompassing target discovery and validation, hit finding, lead optimization, and IND enabling studies to support accelerated drug discovery for this exciting new modality.
Key Learning Objectives:
- Integrated solutions for the discovery of targeted protein degraders
- Selection strategies for diversified in vitro assays
- Drug-resistant in vivo models to support target protein degradation research
Who Should Attend:
- Researchers working on targeted protein degraders
- Researchers working on undruggable targets
- Scientists seeking new solutions and strategies for the discovery of targeted protein degraders